Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells.
about
Cancer-testis antigens: the current status on antigen regulation and potential clinical use.Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
P2860
Core promoter sequence of SEMG I spans between the two putative GATA-1 binding domains and is responsive to IL-4 and IL-6 in myeloma cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Core promoter sequence of SEMG ...... L-4 and IL-6 in myeloma cells.
@en
type
label
Core promoter sequence of SEMG ...... L-4 and IL-6 in myeloma cells.
@en
prefLabel
Core promoter sequence of SEMG ...... L-4 and IL-6 in myeloma cells.
@en
P2093
P2860
P1433
P1476
Core promoter sequence of SEMG ...... L-4 and IL-6 in myeloma cells.
@en
P2093
Jian Zhang
Seah H Lim
Yana Zhang
Zhiqing Wang
P2860
P304
P356
10.1016/J.LEUKRES.2008.05.021
P577
2008-07-07T00:00:00Z